These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 17699335)

  • 21. Sample size and the probability of a successful trial.
    Chuang-Stein C
    Pharm Stat; 2006; 5(4):305-9. PubMed ID: 17128428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. When less is more: using shrinkage to increase accuracy.
    Wears RL; Normand SL
    Ann Emerg Med; 2010 Jun; 55(6):553-5. PubMed ID: 20494223
    [No Abstract]   [Full Text] [Related]  

  • 23. Further discussion on the design and analysis of thorough QTc clinical trials: guest editors' notes.
    Tsong Y; Zhang J
    J Biopharm Stat; 2010 May; 20(3):493-6. PubMed ID: 20358431
    [No Abstract]   [Full Text] [Related]  

  • 24. Studying the prevention of acute kidney injury: lessons from an 18th-century mathematician.
    Chertow GM; Palevsky PM; Greene T
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1124-7. PubMed ID: 17699335
    [No Abstract]   [Full Text] [Related]  

  • 25. Diagnosing model diagnostics.
    Karlsson MO; Savic RM
    Clin Pharmacol Ther; 2007 Jul; 82(1):17-20. PubMed ID: 17571070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials.
    Daimon T
    Contemp Clin Trials; 2008 Jul; 29(4):507-16. PubMed ID: 18201944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing outcomes on peritoneal and hemodialysis: a case study in the interpretation of observational studies.
    Davies SJ
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):24-30. PubMed ID: 17237887
    [No Abstract]   [Full Text] [Related]  

  • 28. [Analysis and importance of statistical power and sample size in empirical scientific research].
    Klimek KM
    Wiad Lek; 2008; 61(7-9):211-5. PubMed ID: 19172834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrast-induced acute kidney injury (CIAKI).
    Solomon R
    Radiol Clin North Am; 2009 Sep; 47(5):783-8, v. PubMed ID: 19744593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interpretation of clinical trial results.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S114-20. PubMed ID: 19007606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating statistics in clinical trials: making the unintelligible intelligible.
    Gilmore SJ
    Australas J Dermatol; 2008 Nov; 49(4):177-84; quiz 185-6. PubMed ID: 18855776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrast-induced nephropathy: prevention and management of high-risk patients.
    Caixeta A; Nikolsky E; Mehran R
    Indian Heart J; 2008; 60(6):524-31. PubMed ID: 19276490
    [No Abstract]   [Full Text] [Related]  

  • 33. Sample size re-estimation in clinical trials.
    Proschan MA
    Biom J; 2009 Apr; 51(2):348-57. PubMed ID: 19358221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical research of kidney diseases V: extended analytic models.
    Ravani P; Parfrey P; Gadag V; Malberti F; Barrett B
    Nephrol Dial Transplant; 2008 May; 23(5):1484-92. PubMed ID: 18424464
    [No Abstract]   [Full Text] [Related]  

  • 35. Statistics review 9: one-way analysis of variance.
    Bewick V; Cheek L; Ball J
    Crit Care; 2004 Apr; 8(2):130-6. PubMed ID: 15025774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Paradigms and pragmatism].
    Healy MJ
    Rev Epidemiol Sante Publique; 1999 Apr; 47(2):185-9. PubMed ID: 10367305
    [No Abstract]   [Full Text] [Related]  

  • 37. Non-dialytic management of sepsis-induced acute kidney injury.
    Rajapakse S; Wijewickrama ES
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):975-83. PubMed ID: 19861856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevention of contrast-induced nephropathy and management of high-risk patients].
    Marenzi G
    G Ital Cardiol (Rome); 2009 Feb; 10(2):88-96. PubMed ID: 19348145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From trial and error to trial simulation. Part 1: the importance of model-based drug development for antidepressant drugs.
    Santen G; van Zwet E; Danhof M; Della Pasqua O
    Clin Pharmacol Ther; 2009 Sep; 86(3):248-54. PubMed ID: 19657333
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.